Stockscreener 앱 받기
15.66
4.04%
-0.66
시간 외 거래:
15.66
Zenas Biopharma Inc 주식(ZBIO)의 최신 뉴스
What analysts say about Zenas BioPharma Inc. stockFree Investment Case Studies - PrintWeekIndia
What drives Zenas BioPharma Inc. stock priceConsistent high-yield stocks - PrintWeekIndia
Is Zenas BioPharma Inc. a good long term investmentFree Real-Time Stock Data - PrintWeekIndia
Zenas BioPharma Inc. Stock Analysis and ForecastOutstanding trading profits - jammulinksnews.com
IgG4-Related Disease Market Outlook Driven by Advancing - openPR.com
What makes Zenas BioPharma Inc. stock price move sharplyFree Stock Market Group - beatles.ru
Why Zenas BioPharma Inc. stock attracts strong analyst attentionHigh Return Investment Tips - Newser
How Zenas BioPharma Inc. stock performs during market volatilityFree Stock Tips Group - Newser
Zenas BioPharma Insiders Added US$2.11m Of Stock To Their Holdings - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Reach Out - ACCESS Newswire
Citi reiterates Buy rating on Zenas Biopharma stock with $27 price target - Investing.com Canada
ZBIO Crosses Above Key Moving Average Level - Nasdaq
Zenas Biopharma shares rise 1.08% in after-hours following strong market growth report for bispecific antibodies and BiTEs. - AInvest
Morgan Stanley assumes coverage on Zenas Biopharma stock with Overweight rating - Investing.com Canada
Innovative Approach and Upcoming Catalysts Drive Buy Rating for Zenas BioPharma - TipRanks
Zenas BioPharma, Inc.(NasdaqGS: ZBIO) dropped from Russell 2000 Growth Index - MarketScreener
Rhumbline Advisers Sells 27,428 Shares of Zenas BioPharma, Inc. (NASDAQ:ZBIO) - Defense World
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas BioPharma, Inc. of Class Action Lawsuit and Upcoming DeadlinesZBIO - Finansavisen
ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
ZBIO LAWSUIT ALERT: Levi & Korsinsky Notifies Zenas - GlobeNewswire
ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - Business Wire
Securities Fraud Class Action Filed Against Zenas BioPharma, Inc. (ZBIO)Levi & Korsinsky Reminds Investors of June 16, 2025 - ACCESS Newswire
ZBIO Investors Have Final Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - marketscreener.com
FINAL ALERT NOTICEZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsZBIO - marketscreener.com
June 16, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against ZBIO - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - The Malaysian Reserve
Join Class Action to Recover Losses from Zenas BioPharma, Inc. (ZBIO)Contact Levi & Korsinsky Before June 16, 2025 - ACCESS Newswire
Investor Alert: Deadline Approaching to Join Zenas BioPharma, Inc. (ZBIO) Class ActionContact Levi & Korsinsky - ACCESS Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - StreetInsider
0.97%
0.22%
자본화:
|
볼륨(24시간):